- Investing Ideas
- /
- German Potentially Undervalued Companies
German Potentially Undervalued Companies
UPDATED Apr 23, 2024
Companies with a Value score of at least 3, ordered by Value score
6,952 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
7C4 | CA$3.62 | -7.2% | 109.2% | CA$1.3b | CA$4.36 | PE8.3x | E1.6% | 2.2% | Energy | ||
JWG1 | UK£1.77 | 5.0% | -27.2% | UK£1.0b | UK£2.40 | PB0.4x | E89.1% | 0% | Energy | ||
5R9 | HK$0.28 | -12.6% | -35.3% | HK$4.0b | n/a | PE7.6x | E14.5% | 6.6% | Real Estate Management and Development | ||
3DJ | UK£1.89 | 8.0% | 21.2% | UK£142.7m | UK£2.53 | PE11.5x | E9.0% | 4.5% | Retail | ||
2D7 | UK£7.60 | -1.9% | 17.8% | UK£4.4b | UK£9.48 | PE5.3x | E-4.1% | 2.1% | Insurance | ||
0L5 | US$76.96 | -0.08% | -23.8% | US$11.9b | US$102.31 | PE11x | E0.3% | 1.7% | Food, Beverage & Tobacco | ||
1FY | US$3.76 | 3.3% | 88.0% | US$1.4b | US$5.28 | PB1.3x | E55.9% | n/a | Media | ||
SWI | HK$7.22 | 2.1% | 9.5% | HK$80.2b | HK$8.77 | PE3x | E-18.3% | 5.2% | Real Estate Management and Development | ||
30L3 | €1.84 | -1.7% | -15.8% | €205.7m | €2.63 | PB1.9x | E102.0% | n/a | Software | ||
FSRA | R2.94 | -1.3% | -5.8% | R346.1b | R3.58 | PE9.1x | E9.5% | 6.5% | Diversified Financials | ||
GFT | €28.35 | 3.8% | -18.7% | €747.7m | €45.32 | PE15.5x | E14.4% | 1.8% | Software | ||
2DT | US$4.96 | -3.7% | 220.0% | US$1.7b | US$6.70 | PB84.4x | E104.9% | 0% | Pharmaceuticals & Biotech | ||
LCQ | R8.85 | 0% | -5.9% | R43.0b | R11.27 | PE3.8x | E-7.7% | 12.1% | Energy | ||
C520 | US$51.50 | -2.8% | -1.9% | US$3.0b | US$69.82 | PS1.8x | E83.1% | n/a | Healthcare | ||
C7E | €13.55 | -0.4% | -28.5% | €182.7m | €20.93 | PB0.7x | E97.3% | n/a | Healthcare | ||
S2P | HK$0.61 | -0.8% | -42.5% | HK$13.4b | HK$1.01 | PE17.4x | E24.4% | 3.3% | Pharmaceuticals & Biotech | ||
CTH | HK$0.56 | 9.4% | 3.7% | HK$16.4b | n/a | PE6.4x | E2.1% | 6.4% | Transportation | ||
IDP | US$184.65 | -1.4% | -27.9% | US$28.2b | US$277.99 | PE24.2x | E18.2% | n/a | Pharmaceuticals & Biotech | ||
PHGN | €0.89 | -8.8% | -11.1% | €611.5m | €1.96 | PS2.7x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
G4L | Mex$0.62 | -6.1% | 13.8% | Mex$57.7b | n/a | PB2.6x | S2.1% | 3.2% | Capital Goods | ||
COY | US$37.39 | -2.4% | 2.2% | US$9.2b | US$47.79 | PE9.7x | E7.4% | 3.5% | Consumer Durables | ||
APPH | €8.00 | -0.7% | -22.0% | €67.1m | €17.37 | PS1.8x | E79.9% | n/a | Pharmaceuticals & Biotech | ||
D6H | €45.90 | 5.5% | -29.2% | €382.4m | €75.75 | PE14.2x | E11.8% | 3.3% | Software | ||
7FZ | zł121.00 | 1.7% | 7.5% | zł7.6b | zł155.69 | PE9.7x | E9.2% | 0.1% | Retail |